Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Neuropharmacology. 2013 Jan 29;70:218–227. doi: 10.1016/j.neuropharm.2013.01.014

Figure 8.

Figure 8

Effect of pretreatment with the 5-HT2A antagonist M100907 on the locomotor response to 25 mg/kg mescaline. Mice were pretreated with 0.03 mg/kg M100907 (A) or 0.1 mg/kg M100907 (B). Mice used were male C57BL/6J. Data are presented as group means±SEM for successive 10-min intervals. *p<0.05, **p<0.01, significant difference from vehicle control group. #p<0.05, ##p<0.001, significant difference from mescaline alone.